Andere Sprachen Maravai LifeSciences Holdings, Inc.

Aktien

A2QHK8

US56600D1072

MRVI

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 24.05.2024			% 5 Tage	% 1. Jan.
10,85 ^USD	+0,65 %		-4,32 %	+65,65 %

15.05.	Transcript : Maravai LifeSciences Holdings, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-15-2024 03:35 PM
09.05.	MARAVAI LIFESCIENCES HOLDINGS, INC. : UBS bleibt neutral	ZM

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center	13.05.
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule	09.05.
Maravai LifeSciences : Conflict Minerals Statement	08.05.
Maravai LifeSciences : Q1 2024 Earnings	08.05.
Earnings Flash (MRVI) MARAVAI LIFESCIENCES HOLDINGS LLC Reports Q1 Revenue $64.2M, vs. Street Est of $60.5M	08.05.
Maravai LifeSciences Reports First Quarter 2024 Financial Results	08.05.
Maravai LifeSciences Holdings, Inc. Reaffirms Financial Guidance for the Full Year 2024	08.05.
Maravai LifeSciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08.05.
TriLink BioTechnologies and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap mRNA Capping Technology	01.05.
TriLink BioTechnologies® et Lonza signent un contrat de licence et d'approvisionnement non exclusif pour la technologie de capsulage d'ARNm CleanCap®	30.04.
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology	30.04.
TriLink BioTechnologies Announces New San Diego Facility for Late Phase mRNA Drug Substance Production	19.04.
TriLink BioTechnologies® annonce un nouveau site à San Diego pour la production de substances médicamenteuses à base d'ARNm au stade ultime de leur développement	18.04.
Maravai LifeSciences Unit Opens New Manufacturing Facility in San Diego	18.04.
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production	18.04.
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024	10.04.
Dyadic International Inc. (NASDAQ: DYAI) Funding to Propel Near-Term Revenue Growth Initiatives Highlights in Zacks Small-Cap Research Report	04.04.
Maravai LifeSciences Announces March 2024 Investor Conference Schedule	12.03.
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS	28.02.
Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI	27.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Maravai LifeSciences Holdings, Inc.

Aktien

A2QHK8

US56600D1072

MRVI

Andere Sprachen

Filter